Literature DB >> 19650176

Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.

J Spiliotis1, A Rogdakis, A Vaxevanidou, A Datsis, G Zacharis, A Christopoulou.   

Abstract

PURPOSE: Peritoneal carcinomatosis (PC), which has been regarded as a lethal condition, may now be treated, achieving a long-term disease-free survival with cytoreductive surgery by treating macroscopic tumor seeding and hyperthermic intraperitoneal chemotherapy (HIPEC) by treating residual microscopic disease. The purpose of this study was to analyse the morbidity and mortality of this procedure.
METHODS: A total of 39 consecutive patients were included in this retrospective study. After complete resection of the PC, HIPEC was performed via the coliseum technique. The chemotherapeutic agents used depended on the tumors' histology.
RESULTS: Postoperative mortality and morbidity rates were 5.1%% (2/39) and 43.5% (17/39), respectively. The most frequent complications were pulmonary complications (31%), gastrointestinal fistulas (20%), hematologic toxicity (16%) and postoperative bleeding (11%). Statistical correlations were evidenced between morbidity and PC index (p<0.004), duration of surgery (p<0.001) and blood loss (p<0.001).
CONCLUSION: This approach has resulted in a relatively high but acceptable percent of adverse events considering the expected advantage for survival.

Entities:  

Mesh:

Year:  2009        PMID: 19650176

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

1.  Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis.

Authors:  Zhou Li; Juan de Dios Redondo Ntutumu; Shengyi Huang; Zhai Cai; Shuai Han; A I Balde; Zeyu Luo; Suzhen Fang
Journal:  Surg Endosc       Date:  2020-07-06       Impact factor: 4.584

2.  Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC.

Authors:  E Halkia; A Tsochrinis; D T Vassiliadou; A Pavlakou; A Vaxevanidou; A Datsis; E Efstathiou; J Spiliotis
Journal:  Int J Surg Oncol       Date:  2015-02-15

Review 3.  Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research.

Authors:  Foteini Stefania Koumpa; Diamantis Xylas; Maciej Konopka; Dieter Galea; Kirill Veselkov; Anthony Antoniou; Akash Mehta; Reza Mirnezami
Journal:  Gastroenterol Res Pract       Date:  2019-04-01       Impact factor: 2.260

4.  Diagnosis and management of peritoneal metastases from ovarian cancer.

Authors:  Evgenia Halkia; John Spiliotis; Paul Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-19       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.